Orna Fennelly
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Orna Fennelly has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Caitriona Cunningham
School of Public Health, Physiotherapy and Sports Science University College Dublin Dublin Ireland
7 shared publications - Catherine Blake
University College Dublin
4 shared publications François Desmeules
School of Rehabilitation, Faculty of Medicine University of Montreal Montreal Quebec Canada
3 shared publications- François Desmeules
École de réadaptation, Faculté de Médecine, Université de Montréal, Montreal, Canada
3 shared publications - Oliver FitzGerald
Conway Institute for Biomolecular Research, School of Medicine, University College Dublin, Dublin, Ireland
3 shared publications Roisin Breen
Health Service Executive Dublin Ireland
3 shared publications
Latest Publications
- Open Access
- 24 September 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e87806
AI in Neurological Health Care: Qualitative Study of Patient and Public Perceptions
Background: Globally, health systems face increasing challenges due to improved life expectancy, rising levels of disease, greater expectations for health care, and growing expenditure. AI-based technologies are increasingly used to support clinical decision-making and contribute to effective delivery of care. AI has significant potential in terms of diagnostics and treatment for preventive and personalized medicine, including progressive, nonprogressive, or neurodivergent conditions affecting the brain, spinal cord, and nerves. Although AI has been extensively applied to several areas of health, its application to neurological conditions remains limited. Objective: This qualitative study explores the perspectives of patients and the public impacted by neurological conditions on the use of AI in health care in Ireland. It focused on the benefits and concerns regarding AI implementation to inform effective and safe use of AI in clinical decision-making. Methods: We conducted a qualitative cross-sectional study using focus groups of patients and the public (family members). A combination of purposive and snowball sampling was used in participant recruitment. The sample consisted of 15 participants involved in 2 focus groups, most commonly with conditions including early-onset Parkinson disease, epilepsy, and multiple sclerosis. Qualitative data were transcribed, and thematic data analysis was undertaken using NVivo (version 12; Lumivero) software. Results: The main benefits of AI in clinical decision-making included improved diagnostics and treatment for neurological health care, increased patient involvement in care and decision-making, and resource efficiency. Participants believed that AI-powered systems could assist with information collation and decision-making, and AI could be an aid in simple repetitive tasks, allowing clinicians more time for clinical work. The concerns included preparedness of the national health data ecosystem, harm resulting from AI application, and overreliance on AI resulting in deskilling. Participants were generally supportive of AI in clinical decision-making; however, their support was conditional on a stringent regulatory framework and human supervision over AI use. Conclusions: Neurological conditions have a significant impact on the lives of patients and their families, with large resource implications for the health care system. AI has the potential to contribute to significant benefits, such as improved diagnostics, resource efficiency, novel insights, and improved provision of health care. However, the health care system needs to focus on the readiness and availability of health data. This study highlights the importance of preparing health systems for the expansion of AI systems, including supporting clinicians and patients in the appropriate and safe implementation of AI in health care.
- 24 September 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e87806
Open AccessAI in Neurological Health Care: Qualitative Study of Patient and Public Perceptions
Background: Globally, health systems face increasing challenges due to improved life expectancy, rising levels of disease, greater expectations for health care, and growing expenditure. AI-based technologies are increasingly used to support clinical decision-making and contribute to effective delivery of care. AI has significant potential in terms of diagnostics and treatment for preventive and personalized medicine, including progressive, nonprogressive, or neurodivergent conditions affecting the brain, spinal cord, and nerves. Although AI has been extensively applied to several areas of health, its application to neurological conditions remains limited. Objective: This qualitative study explores the perspectives of patients and the public impacted by neurological conditions on the use of AI in health care in Ireland. It focused on the benefits and concerns regarding AI implementation to inform effective and safe use of AI in clinical decision-making. Methods: We conducted a qualitative cross-sectional study using focus groups of patients and the public (family members). A combination of purposive and snowball sampling was used in participant recruitment. The sample consisted of 15 participants involved in 2 focus groups, most commonly with conditions including early-onset Parkinson disease, epilepsy, and multiple sclerosis. Qualitative data were transcribed, and thematic data analysis was undertaken using NVivo (version 12; Lumivero) software. Results: The main benefits of AI in clinical decision-making included improved diagnostics and treatment for neurological health care, increased patient involvement in care and decision-making, and resource efficiency. Participants believed that AI-powered systems could assist with information collation and decision-making, and AI could be an aid in simple repetitive tasks, allowing clinicians more time for clinical work. The concerns included preparedness of the national health data ecosystem, harm resulting from AI application, and overreliance on AI resulting in deskilling. Participants were generally supportive of AI in clinical decision-making; however, their support was conditional on a stringent regulatory framework and human supervision over AI use. Conclusions: Neurological conditions have a significant impact on the lives of patients and their families, with large resource implications for the health care system. AI has the potential to contribute to significant benefits, such as improved diagnostics, resource efficiency, novel insights, and improved provision of health care. However, the health care system needs to focus on the readiness and availability of health data. This study highlights the importance of preparing health systems for the expansion of AI systems, including supporting clinicians and patients in the appropriate and safe implementation of AI in health care.
- Open Access
- 14 November 2025
- Published by JMIR Publications Inc. in JMIR Preprints
AI in Neurological Health Care: Qualitative Study of Patient and Public Perceptions (Preprint)
BACKGROUND Globally, health systems face increasing challenges due to improved life expectancy, rising levels of disease, greater expectations for health care, and growing expenditure. AI-based technologies are increasingly used to support clinical decision-making and contribute to effective delivery of care. AI has significant potential in terms of diagnostics and treatment for preventive and personalized medicine, including progressive, nonprogressive, or neurodivergent conditions affecting the brain, spinal cord, and nerves. Although AI has been extensively applied to several areas of health, its application to neurological conditions remains limited. OBJECTIVE This qualitative study explores the perspectives of patients and the public impacted by neurological conditions on the use of AI in health care in Ireland. It focused on the benefits and concerns regarding AI implementation to inform effective and safe use of AI in clinical decision-making. METHODS We conducted a qualitative cross-sectional study using focus groups of patients and the public (family members). A combination of purposive and snowball sampling was used in participant recruitment. The sample consisted of 15 participants involved in 2 focus groups, most commonly with conditions including early-onset Parkinson disease, epilepsy, and multiple sclerosis. Qualitative data were transcribed, and thematic data analysis was undertaken using NVivo (version 12; Lumivero) software. RESULTS The main benefits of AI in clinical decision-making included improved diagnostics and treatment for neurological health care, increased patient involvement in care and decision-making, and resource efficiency. Participants believed that AI-powered systems could assist with information collation and decision-making, and AI could be an aid in simple repetitive tasks, allowing clinicians more time for clinical work. The concerns included preparedness of the national health data ecosystem, harm resulting from AI application, and overreliance on AI resulting in deskilling. Participants were generally supportive of AI in clinical decision-making; however, their support was conditional on a stringent regulatory framework and human supervision over AI use. CONCLUSIONS Neurological conditions have a significant impact on the lives of patients and their families, with large resource implications for the health care system. AI has the potential to contribute to significant benefits, such as improved diagnostics, resource efficiency, novel insights, and improved provision of health care. However, the health care system needs to focus on the readiness and availability of health data. This study highlights the importance of preparing health systems for the expansion of AI systems, including supporting clinicians and patients in the appropriate and safe implementation of AI in health care.
- 14 November 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessAI in Neurological Health Care: Qualitative Study of Patient and Public Perceptions (Preprint)
BACKGROUND Globally, health systems face increasing challenges due to improved life expectancy, rising levels of disease, greater expectations for health care, and growing expenditure. AI-based technologies are increasingly used to support clinical decision-making and contribute to effective delivery of care. AI has significant potential in terms of diagnostics and treatment for preventive and personalized medicine, including progressive, nonprogressive, or neurodivergent conditions affecting the brain, spinal cord, and nerves. Although AI has been extensively applied to several areas of health, its application to neurological conditions remains limited. OBJECTIVE This qualitative study explores the perspectives of patients and the public impacted by neurological conditions on the use of AI in health care in Ireland. It focused on the benefits and concerns regarding AI implementation to inform effective and safe use of AI in clinical decision-making. METHODS We conducted a qualitative cross-sectional study using focus groups of patients and the public (family members). A combination of purposive and snowball sampling was used in participant recruitment. The sample consisted of 15 participants involved in 2 focus groups, most commonly with conditions including early-onset Parkinson disease, epilepsy, and multiple sclerosis. Qualitative data were transcribed, and thematic data analysis was undertaken using NVivo (version 12; Lumivero) software. RESULTS The main benefits of AI in clinical decision-making included improved diagnostics and treatment for neurological health care, increased patient involvement in care and decision-making, and resource efficiency. Participants believed that AI-powered systems could assist with information collation and decision-making, and AI could be an aid in simple repetitive tasks, allowing clinicians more time for clinical work. The concerns included preparedness of the national health data ecosystem, harm resulting from AI application, and overreliance on AI resulting in deskilling. Participants were generally supportive of AI in clinical decision-making; however, their support was conditional on a stringent regulatory framework and human supervision over AI use. CONCLUSIONS Neurological conditions have a significant impact on the lives of patients and their families, with large resource implications for the health care system. AI has the potential to contribute to significant benefits, such as improved diagnostics, resource efficiency, novel insights, and improved provision of health care. However, the health care system needs to focus on the readiness and availability of health data. This study highlights the importance of preparing health systems for the expansion of AI systems, including supporting clinicians and patients in the appropriate and safe implementation of AI in health care.
- 8 January 2024
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 183, 105335
Key interoperability Factors for patient portals and Electronic health Records: A scoping review
- 8 January 2024
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 183, 105335
Key interoperability Factors for patient portals and Electronic health Records: A scoping review
- Top Cited PapersOpen Access
- 1 May 2021
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 149, 104431
Use of standardized terminologies in clinical practice: A scoping review
- 1 May 2021
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 149, 104431
Top Cited PapersOpen AccessUse of standardized terminologies in clinical practice: A scoping review
- Top Cited PapersOpen Access
- 1 December 2020
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 144, 104281
Successfully implementing a national electronic health record: a rapid umbrella review
- 1 December 2020
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 144, 104281
Top Cited PapersOpen AccessSuccessfully implementing a national electronic health record: a rapid umbrella review
- 1 October 2020
- Published by Elsevier in Musculoskeletal Science and Practice
- Vol. 49, 102211
Response to letter to the editor regarding “advanced musculoskeletal physiotherapy practice: Informing education curricula"
- 1 October 2020
- Published by Elsevier in Musculoskeletal Science and Practice
- Vol. 49, 102211
Response to letter to the editor regarding “advanced musculoskeletal physiotherapy practice: Informing education curricula"
- Open Access
- 1 August 2020
- Published by Elsevier in Musculoskeletal Science and Practice
- Vol. 48, 102174
Advanced musculoskeletal physiotherapy practice: Informing education curricula
- 1 August 2020
- Published by Elsevier in Musculoskeletal Science and Practice
- Vol. 48, 102174
Open AccessAdvanced musculoskeletal physiotherapy practice: Informing education curricula
- 1 February 2020
- Published by Elsevier in Musculoskeletal Science and Practice
- Vol. 45, 102077
Advanced musculoskeletal physiotherapy practice: The patient journey and experience
- 1 February 2020
- Published by Elsevier in Musculoskeletal Science and Practice
- Vol. 45, 102077
Advanced musculoskeletal physiotherapy practice: The patient journey and experience
- Open Access
- 21 June 2018
- Published by Wiley in Musculoskeletal Care
- Vol. 16 (4) , 425-432
Advanced musculoskeletal physiotherapy practice in Ireland: A National Survey
Background: Since 2011, advanced practice physiotherapists (APPs) have triaged the care of patients awaiting orthopaedic and rheumatology consultant/specialist doctor appointments in Ireland. APP services have evolved across the major hospitals (n = 16) and, after 5 years, profiling and evaluation of APP services was warranted. The present study profiled the national musculoskeletal APP services, focusing on service, clinician and patient outcome factors.Methods: An online survey of physiotherapists in the allocated APP posts (n = 25) explored: service organization; clinician profile and experience of the advanced role; and patient wait times and outcome measures. Descriptive statistics were used to analyse hospital‐ and clinician‐specific data, and a content analysis was performed to explore APP experiences.Results: A 68% (n = 17) response from 13 sites was achieved, whereby 20 whole‐time APP posts existed in services led by 91 consultant doctors. Co‐location of APP and consultant clinics at 11 sites facilitated joint medical–APP processes, with between‐site differences in autonomy to screen referral letters, and arrange investigations, injections and surgery. Although 83% had postgraduate qualifications, APPs also availed themselves of informal role‐specific training. Positive APP experiences related to learning opportunities and clinical support networks but experiences were consultant dependent, with further service developments and formal training required to manage workloads. APPs reported reduced wait times and most commonly chose to capture function/disability in future evaluations.Conclusions: Variances existed in the organizational design and operating of APP services. Although highly experienced and qualified, APPs welcomed additional formal training and support, due to the complex, more medical nature of APP roles. Further formal evaluation, capturing patient outcomes, is proposed.
- 21 June 2018
- Published by Wiley in Musculoskeletal Care
- Vol. 16 (4) , 425-432
Open AccessAdvanced musculoskeletal physiotherapy practice in Ireland: A National Survey
Background: Since 2011, advanced practice physiotherapists (APPs) have triaged the care of patients awaiting orthopaedic and rheumatology consultant/specialist doctor appointments in Ireland. APP services have evolved across the major hospitals (n = 16) and, after 5 years, profiling and evaluation of APP services was warranted. The present study profiled the national musculoskeletal APP services, focusing on service, clinician and patient outcome factors.Methods: An online survey of physiotherapists in the allocated APP posts (n = 25) explored: service organization; clinician profile and experience of the advanced role; and patient wait times and outcome measures. Descriptive statistics were used to analyse hospital‐ and clinician‐specific data, and a content analysis was performed to explore APP experiences.Results: A 68% (n = 17) response from 13 sites was achieved, whereby 20 whole‐time APP posts existed in services led by 91 consultant doctors. Co‐location of APP and consultant clinics at 11 sites facilitated joint medical–APP processes, with between‐site differences in autonomy to screen referral letters, and arrange investigations, injections and surgery. Although 83% had postgraduate qualifications, APPs also availed themselves of informal role‐specific training. Positive APP experiences related to learning opportunities and clinical support networks but experiences were consultant dependent, with further service developments and formal training required to manage workloads. APPs reported reduced wait times and most commonly chose to capture function/disability in future evaluations.Conclusions: Variances existed in the organizational design and operating of APP services. Although highly experienced and qualified, APPs welcomed additional formal training and support, due to the complex, more medical nature of APP roles. Further formal evaluation, capturing patient outcomes, is proposed.
- Open Access
- 1 June 2018
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 19 (1) , 181
Advanced practice physiotherapy-led triage in Irish orthopaedic and rheumatology services: national data audit
Many people with musculoskeletal (MSK) disorders wait several months or years for Consultant Doctor appointments, despite often not requiring medical or surgical interventions. To allow earlier patient access to orthopaedic and rheumatology services in Ireland, Advanced Practice Physiotherapists (APPs) were introduced at 16 major acute hospitals. This study performed the first national evaluation of APP triage services. Throughout 2014, APPs (n = 22) entered clinical data on a national database. Analysis of these data using descriptive statistics determined patient wait times, Consultant Doctor involvement in clinical decisions, and patient clinical outcomes. Chi square tests were used to compare patient clinical outcomes across orthopaedic and rheumatology clinics. A pilot study at one site identified re-referral rates to orthopaedic/rheumatology services of patients managed by the APPs. In one year, 13,981 new patients accessed specialist orthopaedic and rheumatology consultations via the APP. Median wait time for an appointment was 5.6 months. Patients most commonly presented with knee (23%), lower back (22%) and shoulder (15%) disorders. APPs made autonomous clinical decisions regarding patient management at 77% of appointments, and managed patient care pathways without onward referral to Consultant Doctors in more than 80% of cases. Other onward clinical pathways recommended by APPs were: physiotherapy referrals (42%); clinical investigations (29%); injections administered (4%); and surgical listing (2%). Of those managed by the APP, the pilot study identified that only 6.5% of patients were re-referred within one year. This national evaluation of APP services demonstrated that the majority of patients assessed by an APP did not require onward referral for a Consultant Doctor appointment. Therefore, patients gained earlier access to orthopaedic and rheumatology consultations in secondary care, with most patients conservatively managed.
- 1 June 2018
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 19 (1) , 181
Open AccessAdvanced practice physiotherapy-led triage in Irish orthopaedic and rheumatology services: national data audit
Many people with musculoskeletal (MSK) disorders wait several months or years for Consultant Doctor appointments, despite often not requiring medical or surgical interventions. To allow earlier patient access to orthopaedic and rheumatology services in Ireland, Advanced Practice Physiotherapists (APPs) were introduced at 16 major acute hospitals. This study performed the first national evaluation of APP triage services. Throughout 2014, APPs (n = 22) entered clinical data on a national database. Analysis of these data using descriptive statistics determined patient wait times, Consultant Doctor involvement in clinical decisions, and patient clinical outcomes. Chi square tests were used to compare patient clinical outcomes across orthopaedic and rheumatology clinics. A pilot study at one site identified re-referral rates to orthopaedic/rheumatology services of patients managed by the APPs. In one year, 13,981 new patients accessed specialist orthopaedic and rheumatology consultations via the APP. Median wait time for an appointment was 5.6 months. Patients most commonly presented with knee (23%), lower back (22%) and shoulder (15%) disorders. APPs made autonomous clinical decisions regarding patient management at 77% of appointments, and managed patient care pathways without onward referral to Consultant Doctors in more than 80% of cases. Other onward clinical pathways recommended by APPs were: physiotherapy referrals (42%); clinical investigations (29%); injections administered (4%); and surgical listing (2%). Of those managed by the APP, the pilot study identified that only 6.5% of patients were re-referred within one year. This national evaluation of APP services demonstrated that the majority of patients assessed by an APP did not require onward referral for a Consultant Doctor appointment. Therefore, patients gained earlier access to orthopaedic and rheumatology consultations in secondary care, with most patients conservatively managed.